10:42 AM EDT, 10/30/2024 (MT Newswires) -- bioAffinity Technologies (BIAF) said Wednesday it received a Japanese patent for its CyPath Lung diagnostic test method, which predicts lung cancer risk.
The patent expands bioAffinity's portfolio to 17 granted patents, the company said.
Shares of bioAffinity rose 2.7% in recent trading.
Price: 1.34, Change: +0.03, Percent Change: +2.69